WIPI2 Antikörper (C-Term) (FITC)
-
- Target Alle WIPI2 Antikörper anzeigen
- WIPI2 (WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser WIPI2 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Peptide Affinity Purified
- Immunogen
- Synthetic peptide from the C-terminal of Human WIPI2
- Top Product
- Discover our top product WIPI2 Primärantikörper
-
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) antibody
WIPI2 Reaktivität: Human, Maus WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (AA 4-32), (N-Term) antibodyWIPI2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33312 unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (Atto 594)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal Atto 594
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (FITC)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal FITC
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (Biotin)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal Biotin
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (PE)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal PE
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (PerCP)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal PerCP
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibody (Atto 488)WIPI2 Reaktivität: Human WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal Atto 488
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (AA 205-454) antibodyWIPI2 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2) (C-Term) antibodyWIPI2 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, 50 % glycerol, 0.09 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C.
-
- Target
- WIPI2 (WD Repeat Domain, Phosphoinositide Interacting 2 (WIPI2))
- Andere Bezeichnung
- WIPI2 (WIPI2 Produkte)
- Synonyme
- ATG18B antikoerper, Atg21 antikoerper, WIPI-2 antikoerper, 1110018O08Rik antikoerper, 2510001I10Rik antikoerper, WD repeat domain, phosphoinositide interacting 2 L homeolog antikoerper, WD repeat domain, phosphoinositide interacting 2 antikoerper, wipi2.L antikoerper, WIPI2 antikoerper, Wipi2 antikoerper
- Gen-ID
- 26100
- UniProt
- Q9Y4P8
-
